Prestige Consumer Healthcare
PBH
#4632
Rank
ยฃ1.81 B
Marketcap
ยฃ38.36
Share price
1.36%
Change (1 day)
-22.15%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2026 (TTM): ยฃ2.93

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is ยฃ2.90. In 2025 the company made an earnings per share (EPS) of ยฃ2.80 a decrease over its 2024 EPS that were of ยฃ3.16.

EPS history for Prestige Consumer Healthcare from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)ยฃ2.934.47%
2025ยฃ2.80-11.4%
2024ยฃ3.16-367.08%
2023-ยฃ1.18-138.33%
2022ยฃ3.0911.7%
2021ยฃ2.7713.6%
2020ยฃ2.43-651.67%
2019-ยฃ0.44-148.78%
2018ยฃ0.90-83.29%
2017ยฃ5.41437.23%
2016ยฃ1.01-34.13%
2015ยฃ1.5352.94%
2014ยฃ1.00-8.11%
2013ยฃ1.09
2011ยฃ0.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ6.42 121.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
ยฃ5.14 77.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ5.16 78.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ0.96-66.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ2.65-8.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
ยฃ4.55 56.85%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
ยฃ1.70-41.37%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ2.86-1.36%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
-ยฃ21.79-851.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
ยฃ0.90-69.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel